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Abstract A key component of the current framework for
economic evaluation is the measurement and valuation of
health outcomes using generic preference-based health-re-
lated quality-of-life (HRQoL) instruments. In 2015, a
research synthesis reported the absence of conceptual and
empirical research regarding the appropriateness of current
preference-based instruments for people with aphasia—a
disorder affecting the use and understanding of language—
and suggested the development and validation of an
accessible, pictorial variant could be an appropriate
direction for further research. This paper describes the
respective rationale and development process for each of
three preliminary studies that have been undertaken to
develop pictorial variants of two widely used preference-
based HRQoL instruments (EQ-5D-3L and EQ-5D-5L).
The paper also proposes next steps for this program of
research, drawing on the lessons learned from the prelim-
inary work and the demand for a pictorial preference-based
instrument in the research community. Guidance for the
use of the preliminary, pictorial instruments is also
provided.
Electronic supplementary material The online version of this
article (https://doi.org/10.1007/s41669-018-0083-2) contains supple-
mentary material, which is available to authorized users.
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Key Points for Decision Makers
Modifying questionnaires is sometimes necessary in
order for them to be accessible to certain groups of
respondents, such as individuals living with
communication disorders or learning difficulties.
Developing pictorial versions of widely-used
instruments is an alternative to ‘starting from
scratch’. This approach has the potential to permit
direct comparisons with data obtained from original,
unmodified questionnaires.
This paper describes early, preliminary work in a
line of research that could provide a significant step
towards aligning the current cost-utility framework
with clinical contexts comprising communication
challenges.
1 Introduction
The measurement of health-related quality-of-life (HRQoL)
is an important component in many areas of health research
and policy, such as the routine collection of patient out-
comes, administration of population-level surveys, and the
clinical and economic evaluation of treatments and inter-
ventions. The purpose of a study is the primary consideration
when selecting an appropriate HRQoL instrument to use. In
economic evaluation, where there is a need for studies to
allow for the comparison of findings with those reported
across a broad range of different clinical contexts, generic
preference-based HRQoL instruments are commonly rec-
ommended in national technology appraisal guidelines [1, 2]
and recommendations [3]. These standardized instruments
facilitate the estimation of health state values—often called
utility scores or preference weights—that are used to cal-
culate quality-adjusted life-years (QALYs) [4, 5]. In addition
to permitting the comparability of study findings through the
use of a common metric, this approach enables preferences
from the general public to be incorporated into the mea-
surement of health outcomes.
In the context of aphasia, recent attention has been paid
to the use and suitability of standardized HRQoL instru-
ments that are recommended for use in economic evalua-
tion [6–8]. The US National Institutes of Health defines
aphasia as a ‘‘neurological disorder caused by damage to
the portions of the brain that are responsible for language
production or processing’’ [9]. This language disruption
affects speaking most obviously, but other language
functions—speech comprehension, reading and writing—
are also affected to varying degrees. There is a resulting
critical impact on communication, given that the exchange
of information and viewpoints that are essential to all
human activities are often seriously disturbed [10]. Aphasia
is most often caused by stroke, but it can also result from a
brain tumor, infection, or head injury that damages lan-
guage regions of the brain. Approximately one-third of
individuals who suffer a stroke experience aphasia [11].
Whitehurst et al. [8] identified the absence of any con-
ceptual or empirical research regarding the appropriateness
of current preference-based HRQoL instruments in the
context of aphasia. They concluded that, unlike aphasia-
specific quality-of-life outcome measures that have been
developed in recent years [12–14], current preference-
based HRQoL instruments may not be accessible to indi-
viduals living with aphasia and proposed that the devel-
opment and validation of a pictorial variant of an existing
generic preference-based instrument was an appropriate
research direction. The rationale for this approach drew
from evidence showing that trained individuals using
appropriate resources, such as pictographic material, can
obtain important information from individuals with aphasia
despite significant language barriers [15]. A considerable
literature exists recommending the use of aphasia-friendly
formatting (e.g. pictures, key words, and generous spacing
of graphics) as a method of improving comprehension and
expression of people with aphasia [16–19], although
research that applies such aphasia-friendly formatting to
preference-based HRQoL measures is in its infancy [6, 8].
The purpose of this paper is twofold. First, the paper
describes the respective rationale and development process
for each of three preliminary studies—performed, inde-
pendently, by research groups in Canada and the UK—that
were conducted with the objective of investigating the use
of pictorial variants of two widely used preference-based
HRQoL instruments, the EQ-5D-3L and EQ-5D-5L.
Throughout the paper, the studies are described as ‘pre-
liminary’ so as to emphasize the early-stage, exploratory
nature of this instrument development work. Second, the
paper proposes appropriate next steps for this line of
research, drawing on lessons learned from the preliminary
work and the demand for (and broader application of) a
pictorial preference-based instrument. Guidance for the use
of the preliminary pictorial instruments is also provided.
Before describing the rationales and methods adopted in
the three preliminary studies, the following section pro-
vides a brief description of the key components of generic
preference-based HRQoL instruments and specific details
of the three-level (EQ-5D-3L) and five-level (EQ-5D-5L)
instruments developed by the EuroQol Group. A more
detailed explanation of preference-based instruments,
226 D. G. T. Whitehurst et al.
including descriptions and comparisons of different
instruments, can be found elsewhere [4, 5, 20].
2 Generic Preference-Based HRQoL Instruments
Preference-based HRQoL instruments comprise two com-
ponents: a descriptive classification system and a valuation
system. The descriptive classification system is made up of
the dimension items and respective response options that
allow a respondent to describe their health state as one of a
finite number of possible health states. For example, a
questionnaire with six dimensions (and one item per
dimension), each with four levels of response, defines 4096
(46) unique health states. In other words, there are 4096
different ways of completing the classification system. The
valuation system is the procedure for scoring each health
state defined by an instrument. For generic preference-
based instruments, the numerical scores represent the rel-
ative value that society places on living in each health state.
The set of single index scores are interpreted on a 0–1
scale, where 1 indicates ‘full health’ and zero represents a
health state equivalent to being dead. Negative index
scores are generated by some instruments, where the neg-
ative scores represent ‘worse than dead’ health state valu-
ations. Country-specific sets of scores (known as value sets
or national tariffs) are available for some preference-based
HRQoL instruments, reflecting the fact that preferences for
health states may differ across countries.
A number of preference-based HRQoL instruments have
been developed, dating back to the Rosser–Kind Index
from the late 1970s [4, 21]. Inevitably, some instruments
are more prevalent than others in the field of economic
evaluation. A review of 1663 studies that reported using a
preference-based HRQoL instrument found that the EQ-
5D-3L was the most widely used instrument (64% of
studies) [20]. The descriptive classification system for the
EQ-5D-3L comprises five dimensions (mobility, self-care,
usual activities, pain/discomfort and anxiety/depression),
with each dimension containing a single question that has
three levels of response [see Appendix 1A in the Electronic
Supplementary Material (ESM)] [22]. In 2005, a EuroQol
Group Task Force was set up to investigate possible ways
to improve the sensitivity of the EQ-5D-3L. This work
resulted in the preservation of the same five dimensions,
each with one item per dimension, but with five levels of
response (see Appendix 1B in the ESM) [23]. As of 2016,
there were 176 and 138 official language versions of the
EQ-5D-3L and EQ-5D-5L, respectively [24]; details of
country-specific value sets for the two instruments are
available on the EuroQol website (http://www.euroqol.org/
). In addition to the five questions of the descriptive clas-
sification systems, the EQ-5D-3L and EQ-5D-5L include a
visual analogue scale (EQ VAS), where respondents are
asked to self-rate their health state on a vertical 0–100
VAS. For the EQ-5D-3L, the EQ VAS endpoints are
labelled ‘best imaginable health state’ (at 100) and ‘worst
imaginable health state’ (at zero) (see Appendix 1C in the
ESM), whereas the endpoints of the EQ VAS for the EQ-
5D-5L are labelled ‘the best health you can imagine’ (at
100) and ‘the worst health you can imagine’ (at zero) (see
Appendix 1D in the ESM). EQ VAS provides a quantita-
tive measure of health outcome as judged by the respon-
dent themselves; EQ VAS responses are not used in the
derivation of EQ-5D-3L or EQ-5D-5L index scores.
Almost by definition, generic quality-of-life measures,
whether preference-based or not, will be less sensitive than
condition-specific measures because there is no tailored
focus on aspects of quality-of-life that are specific to the
condition under investigation. The value of using a generic
instrument is in the comparability of findings across clin-
ical specialties (enabling the comparison of cost-effec-
tiveness findings across disease areas) and, typically,
generic and condition-specific quality-of-life instruments
should be viewed as complements rather than substitutes.
In the words of Professor Alan Williams, in reference to
instruments developed by the EuroQol Group, ‘‘The raison
d’eˆtre of the EuroQol instrument is to provide a simple
‘abstracting’ device, for use alongside other more detailed
measures of health-related quality-of-life …, to serve as a
basis for comparing health care outcomes using a basic
‘common core’ of [quality-of-life] characteristics which
most people are known to value highly’’ [25].
3 Preliminary Studies in the UK and Canada
3.1 Rationale
The UK and Canadian research groups became aware of
their complementary interests while conducting a research
synthesis [8], and a decision was made to form a single,
international collaboration. The underlying rationale within
both research groups was the same, i.e., current standard-
ized instruments for measuring generic health outcomes for
use in economic evaluation were likely to be inaccessible
for many individuals living with aphasia. Without a solu-
tion to this issue, economic evaluation of interventions for
individuals with aphasia could still be performed within a
cost-effectiveness (or cost–benefit, or cost-consequence)
framework, where health outcomes could be measured in
several different ways [26]. However, to perform economic
evaluation within a cost-utility framework (without relying
on proxy assessments of HRQoL [27]), where outcomes are
quantified using QALYs and societal preferences, there
was a need to align widely accepted (and often mandated)
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practices in health technology assessment with the specific
challenges of research in the context of aphasia. While the
Canadian research group were interested in this general
methodological void, the UK research group were moti-
vated to include an accessible preference-based HRQoL
instrument in the evaluation of a specific computerized
aphasia therapy [28, 29].
3.2 Instrument Development Processes
The three ‘pilot’ instruments are presented in Appendix 2
in the ESM. Although the development of the Canadian
and UK variants occurred independently, with teams
bringing different experiences and orientations to the task,
all versions aimed at getting around the language barrier by
including pictures/pictographs of the key elements of each
item in the questionnaires. For ease of reference, the fol-
lowing abbreviations are used to distinguish between
instruments: CPI-3L (Canadian Pilot Instrument of the EQ-
5D-3L), UKPI-3L (UK Pilot Instrument of the EQ-5D-3L)
and the UKPI-5L (UK Pilot Instrument of the EQ-5D-5L).
Abbreviations incorporating EuroQol (or ‘EQ’) terminol-
ogy are avoided to prevent misconceptions about the offi-
cial status of any of the pictorial instruments from the
perspective of the EuroQol Group.
The CPI-3L was created as part of an exploratory
investigation into the development of a communicatively
accessible version of the time trade-off (TTO) preference-
elicitation procedure, which is a method to directly mea-
sure the preferences of individuals. Initially, the primary
objective was to create a pictorial version of the standard
TTO exercise and map the pictorial TTO responses to a
previously validated aphasia-specific quality-of-life mea-
sure, the Assessment for Living with Aphasia (ALA)
[10, 30]. The CPI-3L was developed and included as a
secondary consideration, as an alternative to TTO/ALA
mapping for the estimation of QALYs, but the develop-
ment and validation of a pictorial standardized instru-
ment(s) has since become the primary research objective of
the international research collaboration.
The CPI-3L was developed in line with the ‘Supported
Conversation for Adults with Aphasia’ approach, an evi-
dence-based method for reducing language barriers in
various contexts [15]. Pictorial material for the CPI-3L
came from the bank of images (or, where necessary, the
creation of new images) developed and maintained by the
Aphasia Institute (Ontario, Canada). The process included
a series of steps beginning with rough pictorial approxi-
mations of EQ-5D-3L content (i.e. dimensions and
response options) followed by iterations based on feedback
from participant focus groups as well as clinicians. The
Aphasia Institute has access to input from people with
aphasia on a daily basis, and the development of
pictographs, particularly those of a more abstract nature,
often go through many revisions based on this input. As
shown in Appendix 2A in the ESM, the CPI-3L displays
one dimension per page (in portrait orientation), presented
at the top of the page in clear emboldened text. Images are
presented for each level of response. For the ‘self-care’ and
‘usual activities’ dimensions, further images are included
(above the response options) to reflect particular activities
and functioning expressed in the question and response
options, such as dressing, bathing, housework or leisure
activities. The exact wording of EQ-5D-3L response
options is retained in the CPI-3L.
The UKPI-3L and UKPI-5L were created as part of a
randomized controlled trial for self-managed computerized
word-finding treatment for people with aphasia [28, 29].
The UKPI-3L was developed for the CACTUS (Cost-ef-
fectiveness of Aphasia Computer Treatment Compared to
Usual Stimulation) pilot study [6, 28], whereas the UKPI-
5L was developed for the full trial (Big CACTUS) [29]. In
the CACTUS pilot study, two speech and language thera-
pists used aphasia-friendly conventions to inform the
modifications to the standard EQ-5D-3L (see Appendix 2B
in the ESM), which included asking about one health
dimension per page (in landscape orientation), presented at
the top of the page in clear emboldened text; reducing the
response options for each dimension to key words only;
providing a picture to illustrate each response option; and a
symbol (0, ? or ??) to indicate the different levels of
response. For example, the ‘mobility’ dimension is pre-
sented at the top of the first page with each of the three
response options spaced out from left to right in order of
ascending difficulty across a page. Using the first response
option as an example of the wording reduction, ‘I have no
problems in walking about’ was reduced to the emboldened
words ‘no problems’. This response option appears beneath
a line drawing of a man walking his dog and the symbol
‘0’. The illustrations, one per response option for each
dimension, were developed through discussion between a
speech and language therapist and an artist. Once drawn,
these illustrations were taken to a group of four people with
aphasia and their caregivers for feedback on how well the
pictures represented the dimensions and response options,
which informed any final modifications.
The work in the CACTUS pilot study was built on in
preparation for the Big CACTUS trial with a group of four
people with aphasia and their caregivers. The people with
aphasia worked together in one group with a research
speech and language therapist who used a ‘Total Com-
munication’ approach to facilitate understanding of deci-
sions to be made and expressions of preferences [31]. The
caregivers, who were all relatives of the people with
aphasia, worked with a second research speech and lan-
guage therapist discussing their views on the extent to
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which their relatives with aphasia could complete the
pictorial version in a meaningful way and their thoughts on
design features that would facilitate independent comple-
tion of the tool. These two groups, working separately, co-
produced the UKPI-5L (Appendix 2C in the ESM). The
UKPI-3L and the standard EQ-5D-5L were presented to
both groups alongside other aphasia-friendly tools to be
used in the Big CACTUS trial to give ideas of a range of
potential ways that the questions for each dimension could
be presented. Both groups had a preference for a scale
being developed in a similar style to that used by the
Communication Outcome After Stroke (COAST) patient-
rated outcome measure [32], with squares of increasing
size and strength of colour to indicate the extent of diffi-
culty with each dimension, and key words contained within
each square (e.g. ‘unable’, ‘severe problems’ or ‘moderate
problems’). The pictures designed for the UKPI-3L were
reviewed for meaningfulness. Where group members
identified features of the line drawings that could be
improved, these changes were made. In the UKPI-3L, a
line drawing was used to represent each of the three levels
of response. As there are five levels of response in the EQ-
5D-5L, the groups considered how best to use pictures to
facilitate understanding of the five-level scale. The con-
sensus was to have a picture at each end of the scale rep-
resenting the extremes.
4 Contribution and Future Directions
From the outset, it is important to clarify that none of the
instruments described in this paper (and presented in
Appendix 2 in the ESM) should be regarded as a ‘vali-
dated’ tool—this paper describes preliminary method-
ological research only. As with any study intending to use a
EuroQol instrument, researchers should consult the infor-
mation provided on the EuroQol website (www.euroqol.
org). Although the CPI-3L, UKPI-3L and UKPI-5L are not
official variants of the EQ-5D, researchers interested in
these preliminary, pictorial instruments are requested to
follow the same process (see Acknowledgments for further
details).
Awareness of the CPI-3L, UKPI-3L and UKPI-5L has
steadily grown as a result of conference presentations (in-
cluding the American Speech-Language-Hearing Associa-
tion Convention, the Clinical Aphasiology Conference, and
meetings of the EuroQol Group and the UK Health
Economists’ Study Group) and the publication of related
studies [6, 8]. Interest in a pictorial, preference-based
HRQoL instrument also extends beyond application within
the context of aphasia—for example, paediatrics and neu-
rodevelopmental disorders (personal communications)—
hence the focus on developing ‘accessible’ instruments as
opposed to aphasia-specific instruments. The interest and
awareness of our preliminary work was the catalyst for
writing this paper. Despite the absence of formal validation
(to date), documentation of our preliminary work provides
clarity regarding the steps undertaken in this innovative
line of research. The next stage is to develop a full-scale
research program, with the objective of developing and
validating official pictorial EQ-5D instruments. The
development of the British Sign Language version of the
EQ-5D-5L is an example of similar research, where a
variant of a standardized instrument has been created to fit
the needs of a particular subset of community-dwelling
individuals [33].
To achieve our ultimate objective, further research will
need to encompass more than the identification of suit-
able images to depict dimensions and response options of
the EQ-5D-3L and EQ-5D-5L descriptive classification
systems, and simplification of the EQ VAS. As with any
new or modified instrument, the process of development
and validation will require several steps. For example,
early considerations that require the systematic review of
available evidence and/or developmental pilot work
include evaluating the relative merits of using (1) line
drawings compared with photographs, (2) images for every
response option compared with images at the ends of the
scale only, and (3) the same images in different clinical
contexts. Once a new pictorial descriptive classification
system has been developed, examination of measurement
properties will be required, such as the assessment of
practicality, reliability, responsiveness and validity
[34, 35]. The importance of comparability across studies
and conditions was the primary reason for modifying
EuroQol instruments rather than developing a new instru-
ment. Accordingly, the merit of this research endeavour
will rest heavily on the degree to which pictorial versions
of EuroQol instruments provide the same health state
descriptions as those elicited from the standard versions.
One of the final steps in the process would be developing
standardized scripts to accompany the pictorial instru-
ments, which may vary across different modes of admin-
istration (e.g. researcher supported-completion,
family/caregiver supported-completion and self-comple-
tion) and clinical contexts. Given the significant com-
plexities of developing pictorial instruments compared
with more conventional text-based instruments, a further
important issue is whether there is a need for three-level
and five-level pictorial variants. Such decisions will be
influenced, to some extent, by the current research and
debate surrounding the role of the EQ-5D-5L in health
technology assessment [34, 35].
The generic measurement of health outcomes is a
common feature at the intersection of health economics and
healthcare decision making. This paper describes
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preliminary research and future directions with regard to
improving the accessibility of EuroQol instruments through
the development of pictorial variants. Such research will
provide a significant step towards aligning the current cost-
utility framework with clinical contexts comprising com-
munication challenges.
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